Timothy M. Acker, Ph.D.
Institution:
Emory University, Atlanta, GAArea:
Medicinal, Bioorganic, Synthetic Organic, ComputationalGoogle:
"Timothy Acker"Mean distance: 9.82 | S | N | B | C | P |
Parents
Sign in to add mentorDennis C. Liotta | grad student | 2013 | Emory | |
(Structural Determinants of Activity, Mechanism and Structure Activity Relationships of Novel GluN2C/D Subunit Selective Antagonists of the N-methyl-D-Aspartate Receptor.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
D'Erasmo MP, Akins NS, Ma P, et al. (2023) Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the -Methyl-d-aspartate Receptor. Acs Chemical Neuroscience |
Swanger SA, Vance KM, Acker TM, et al. (2017) A novel negative allosteric modulator selective for GluN2C/2D-containing NMDA receptors inhibits synaptic transmission in hippocampal interneurons. Acs Chemical Neuroscience |
Gable JE, Lee GM, Acker TM, et al. (2016) Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease. Chemmedchem |
Acker TM, Khatri A, Vance KM, et al. (2013) Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists. Journal of Medicinal Chemistry. 56: 6434-56 |
Santangelo RM, Acker TM, Zimmerman SS, et al. (2012) Novel NMDA receptor modulators: an update. Expert Opinion On Therapeutic Patents. 22: 1337-52 |
Acker TM, Yuan H, Hansen KB, et al. (2011) Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Molecular Pharmacology. 80: 782-95 |
Mosley CA, Acker TM, Hansen KB, et al. (2010) Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. Journal of Medicinal Chemistry. 53: 5476-90 |